Affinity Asset Advisors’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Affinity Asset Advisors’s Portfolio CHAQ.U Stock Details CHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-75,000	Closed	-$819K	–	90
2021 Q2	$819K	Hold	75,000	–	–	0.29%	58
2021 Q1	$789K	Buy	+75,000	New	+$853K	0.27%	54

Affinity Asset Advisors's CHAQ.U Position: Q3 2021 in Review

Affinity Asset Advisors sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q3 2021, closing a stake of 75,000 shares — an estimated $819K sold.

Affinity Asset Advisors first reported a position in CHAQ.U in Q1 2021 and held it in 2 quarters. The position peaked at $819K in Q2 2021. 0 funds tracked by Wall St. Rank hold CHAQ.U as of Q3 2021.

Affinity Asset Advisors reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q3 2021 after selling out during the quarter.
Affinity Asset Advisors sold 75,000 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q3 2021, an estimated $819K.
Affinity Asset Advisors first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q1 2021 and held it in 2 quarters.
Affinity Asset Advisors's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $819K in Q2 2021.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q3 2021.

Based on Affinity Asset Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.